In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Sunesis raises $45mm with private placement

Executive Summary

Sunesis Pharmaceuticals (small-molecule oncology therapeutics) has raised $45mm from a private placement. It sold 7.25mm common shares--that carry warrants to buy an additional 2.17mm common--for $6.21 each (a 7% premium to the market average). Investors, including Deerfield Management, Baker Brothers Investments, funds managed by Alta Partners, and existing backer Warburg Pincus, paid an additional $0.125 for each share underlying the warrants (equal to $271,250). Cowen & Co. acted as the placement agent.

Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Private Investment in Public Equity
    • Private Placement

Related Companies